ONTX / Onconova Therapeutics, Inc. - Net Long/Short Value

Onconova Therapeutics, Inc.
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

ONTX / Onconova Therapeutics, Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
UBS Group AG
Two Sigma Securities, Llc
Morgan Stanley
Geode Capital Management, Llc
Tower Research Capital LLC (TRC)
Alyeska Investment Group, L.P.
VEXMX - VANGUARD INDEX FUNDS - Vanguard Extended Market Index Fund Investor Shares
BlackRock, Inc.
FCFMX - FIDELITY CONCORD STREET TRUST - Fidelity Series Total Market Index Fund
Orbimed Advisors Llc
Vermillion & White Wealth Management Group, LLC
FSKAX - FIDELITY CONCORD STREET TRUST - Fidelity Total Market Index Fund
FSMAX - FIDELITY CONCORD STREET TRUST - Fidelity Extended Market Index Fund
Bank Of America Corp /de/
Fmr Llc
Citigroup Inc
Adage Capital Partners Gp, L.l.c.
Vestal Point Capital, LP
Vanguard Group Inc
FNCMX - FIDELITY CONCORD STREET TRUST - Fidelity Nasdaq Composite Index Fund
Two Sigma Investments, Lp
Raymond James Financial Inc
SBI Securities Co., Ltd.
Ikarian Capital, LLC
Other Listings
US:TRAW 1,87 $
DE:0T20
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista